Award
Delivery Order #15B20327F00000013
Pharmaceutical Delivery Order for Danbury Inmate Population by McKesson
Buyer
Federal Prison System / Bureau of Prisons
Award Amount
$150,000.00
Ceiling
$150,000.00
Awarded
October 01, 2026
Period of Performance
Oct 01, 2026 – Dec 02, 2026
Identifier
15B20327F00000013
NAICS
325412
This delivery order contract represents a supplemental procurement under a broader indefinite delivery vehicle awarded to McKesson Corporation, a leading pharmaceutical distributor. The contract specifically focuses on supplying pharmaceutical products for the Danbury inmate population, ensuring proper medication management aligned with federal directives prohibiting racially discriminatory diversity, equity, and inclusion activities. McKesson, known for its extensive pharmaceutical distribution network, supports the Department of Veterans Affairs and public health sectors with reliable medication supply chains. The work covers timely delivery of pharmaceutical products to meet the healthcare needs of the specified inmate population. This contract builds upon McKesson's existing Pharmaceutical Prime Vendor Contract, a substantial multi-year agreement enhancing medication access across federal facilities. The award resulted from a task order under a competitive contract vehicle dedicated to pharmaceutical services. The performance period spans a multi-month timeframe in late 2026, marking a critical ongoing effort to maintain continuity and compliance in pharmaceutical provisioning.
Description
PRIME VENDOR PHARMACEUTICAL FOR DANBURY INMATE POPULATION IN ACCORDANCE WITH EO 14398 PROHIBITS FEDERAL CONTRACTORS AND SUBCONTRACTORS FROM ENGAGING IN RACIALLY DISCRIMINATORY DEI ACTIVITIES.